17-32021319-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000341671.12(LRRC37B):āc.173A>Cā(p.Glu58Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000295 in 1,613,738 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000341671.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRC37B | NM_001321350.2 | c.1-74A>C | intron_variant | ENST00000543378.7 | |||
LRRC37B | NM_052888.3 | c.173A>C | p.Glu58Ala | missense_variant | 1/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRC37B | ENST00000543378.7 | c.1-74A>C | intron_variant | 2 | NM_001321350.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 250924Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135726
GnomAD4 exome AF: 0.000285 AC: 417AN: 1461542Hom.: 1 Cov.: 32 AF XY: 0.000304 AC XY: 221AN XY: 727058
GnomAD4 genome AF: 0.000388 AC: 59AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.173A>C (p.E58A) alteration is located in exon 1 (coding exon 1) of the LRRC37B gene. This alteration results from a A to C substitution at nucleotide position 173, causing the glutamic acid (E) at amino acid position 58 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at